Thermal decomposition mechanism of piroxicam

被引:0
作者
Cheng-Jie Wu
Jin-Zong You
Xue-Jie Wang
机构
[1] Zhejiang International Studies University,School of Science and Technology
来源
Journal of Thermal Analysis and Calorimetry | 2018年 / 134卷
关键词
Piroxicam (PRX); Thermal decomposition mechanism; TGA–FTIR; Quantum chemistry;
D O I
暂无
中图分类号
学科分类号
摘要
Piroxicam (PRX) is a nonsteroidal anti-inflammatory drug. The thermal decomposition process of PRX was investigated with thermogravimetry and differential scanning calorimetry. The gaseous products generated by thermal decomposition were characterized with thermogravimetric analysis coupled with Fourier transform infrared spectroscopy. The residues of the thermal decomposition at various temperatures were identified with infrared spectroscopy. The molecular bond orders were calculated using an ab initio method from the GAMESS program of quantum chemistry. The mechanism of thermal decomposition for PRX was discussed. The results indicated that the thermal decomposition of PRX is a two-stage process with the initial temperature of 198 °C either in nitrogen or air atmospheres. The thermal decompositions of the first stage in two atmospheres are the same process. The main part of the molecule, including sulfamide, amide, benzene ring and pyridine ring, decompose simultaneously and to form gasifiable small molecules and carbonaceous residue in the first stage. The second stage in nitrogen is a slow thermal pyrolysis process of carbonaceous residue. The forepart of the second stage in air is a slow thermal pyrolysis process as like as in nitrogen, and the later period of the second stage is an oxidation (combustion) reaction process of carbonaceous residue. PRX is stable under ambient temperature and air atmosphere, and it can be preserved for long-term storage under ambient temperature and in air atmosphere.
引用
收藏
页码:2041 / 2048
页数:7
相关论文
共 126 条
[1]  
March L(2014)Burden of disability due to musculoskeletal (MSK) disorders Best Pract Res Clin Rheumatol 28 353-366
[2]  
Smith EU(2015)Osteoarthritis Lancet 386 376-387
[3]  
Hoy DG(2004)Subchondral bone changes in hand and knee osteoarthritis detected by radiography Osteoarthr Cartil 18 S10-S19
[4]  
Cross MJ(2016)Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys Semin Arthritis Rheum 45 S22-S27
[5]  
Sanchez-Riera L(1985)Effects of age and sex on piroxicam disposition Clin Pharmacol Ther 37 13-18
[6]  
Blyth F(2017)Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam Vet Comp Oncol 15 1346-1353
[7]  
Buchbinder R(2006)Recent advances on non-steroidal anti-inflammatory drugs, NSAIDs: organotin complexes of NSAIDs J Organomet Chem 691 1767-1774
[8]  
Vos T(2011)Complex of anti-inflammatory non-steroidal drugs from oxicam family. 1. Synthesis and characterization of Zn (II) complex with Piroxicam Rev Chim (Bucuresti) 62 1002-1007
[9]  
Woolf AD(2004)Structural characterization and SOD activity of copper–oxaprozinate Inorg Chem Commun 7 1071-1074
[10]  
Glyn-Jones S(2018)Evaluation of thermal stability and kinetic of degradation for levodopa in non-isothermal conditions J Therm Anal Calorim 131 1881-1888